The Food and Drug Administration has approved a first-of-its-kind non-opioid pain medication, providing a new option for adults experiencing moderate to severe acute pain. Journavx received FDA ...
The non-opioid medicine is meant to reduce the likelihood of addiction.
Because the drug doesn’t target the brain, it has less potential for addiction. Learn why this could help the opioid crisis.